Enclomiphene for Low Testosterone in Scarsdale, NY

Enclomiphene is an oral medication that acts on the brain's hormone feedback loop rather than replacing testosterone. It signals the pituitary to release more LH and FSH, and those signals tell the testes to make more testosterone themselves. Testosterone therapy does the opposite: it lowers LH and FSH and suppresses sperm production. That difference is why enclomiphene is designed to preserve sperm production, and why men who are planning a family often ask about it.

Enclomiphene suits a specific lab picture: low testosterone with LH and FSH that are low or normal, meaning the testes can still respond. The baseline panel shows whether that is you.

• Men with symptoms and confirmed low morning testosterone
• Men who want to preserve fertility
• Men whose LH and FSH results suggest the testes can still respond to a signal
• Men who prefer an oral medication and accept regular lab monitoring

Enclomiphene has a shorter and smaller evidence base than testosterone, and its long-term safety is not established.

Regulatory status. Enclomiphene is not FDA-approved for any use. What US physicians prescribe is compounded, and compounded drugs are not FDA-approved.

When it stops. Enclomiphene works while you take it. The effect fades when it is stopped.

Monitoring. Estradiol and hematocrit can rise, which is why labs are rechecked after starting.

Alternatives. hCG also supports sperm production, and testosterone cypionate or gel replaces testosterone directly. Your provider explains which fits your labs and plans.

Works through your own hormones. Enclomiphene raises LH and FSH so the testes make more testosterone, rather than adding testosterone from outside.

Designed to preserve sperm production. Because the testes keep working, enclomiphene is an option for men who want children now or later.

An oral option. Enclomiphene is taken by mouth rather than injected or applied to the skin.

Lab-guided monitoring. LH, FSH, testosterone, estradiol and hematocrit are checked so your provider can see how your body is responding.

Every plan starts with a diagnosis. The steps are the same in the clinic and by telehealth.

1. Evaluation. A provider reviews your symptoms, history and fertility plans.
2. Assessment and morning labs. The Male or Female Hormone & Longevity Assessment ($349) includes bloodwork drawn at the Scarsdale clinic, a SECA body composition scan and a grip strength test. The Telehealth Hormone & Longevity Assessment ($249) reviews bloodwork by video.
3. Choosing the option. Your provider explains enclomiphene, hCG and testosterone side by side and recommends what fits your LH, FSH and goals.
4. Follow-up labs. Labs are rechecked after starting so the plan can be adjusted or changed.

No. Enclomiphene is not FDA-approved for any use, including low testosterone or male infertility. Enclomiphene prescribed in the US is a compounded preparation, and compounded drugs are not FDA-approved.

TRT replaces testosterone and usually suppresses sperm production. Enclomiphene prompts the testes to make more testosterone themselves and is designed to preserve sperm production. We compare them in detail in our TRT vs enclomiphene guide.

Men with confirmed low testosterone whose LH and FSH results show the testes can still respond, especially men who want to preserve fertility. A physician decides based on your labs.

Yes, if you are eligible. Protocol Health offers telehealth in New York, New Jersey, Connecticut, Florida and California, with labs drawn at the Scarsdale clinic or near home.

The effect fades when it is stopped, and testosterone tends to return toward where it started. Your provider plans for that before you begin.